Your browser doesn't support javascript.
loading
Contributing factors to the outcome of primary malignant chest wall tumors.
Abdel Rahman, Abdel Rahman Mohamed; Rahouma, Mohamed; Gaafar, Rabab; Bahaa, Sherif; Loay, Iman; Kamel, Mohamed; Abdelbaki, Hoda; Yahia, Maha.
Afiliação
  • Abdel Rahman ARM; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Rahouma M; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Gaafar R; Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Bahaa S; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Loay I; Cancer Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Kamel M; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Abdelbaki H; Radiation Therapy Department, National Cancer Institute, Cairo University, Cairo, Egypt.
  • Yahia M; Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
J Thorac Dis ; 9(12): 5184-5193, 2017 Dec.
Article em En | MEDLINE | ID: mdl-29312725
ABSTRACT

BACKGROUND:

Primary malignant chest-wall tumors (PMCWTs) are a heterogeneous group of tumors. They require a special experience in designing resection and reconstruction. They account for less than 1% of all primary malignant tumors. This study is designed to clarify different factors contributing to the outcome of patients with PMCWTs in our institution.

METHODS:

A retrospective study included 98 patients with pathology proven PMCWTs, treated at the National Cancer Institute (NCI), Cairo University, Egypt, during the past 10 years. Used variables were age, sex, forced expiratory volume in the 1st second (FEV1), site, size, multiplicity, pathologic subtype, tumor grade, safety margin (SM), excised ribs, complications, estimated blood loss (EBL), neo-adjuvant and adjuvant treatments, Overall and disease free survival (DFS) were obtained using Kaplan-Meier method and compared using Log rank test. Cox regression was used to identify DFS predictors.

RESULTS:

PMCWTs represented 10.5% of all thoracic malignancies in our institution. There were 51 females (52%). The median age was 39 years [interquartile range (IQR) =25-52.3)] years. Chondrosarcoma was the commonest tumor histology (20.4%). The median tumor size was 8 cm (IQR =5-14). Tumor multiplicity was found in 18.4% of patients. Bone resection was performed in 76 patients (78.3%), ribs resection was performed in 59 patients and the median number of resected ribs per patient was 3 (IQR =1-3) ribs. Sternal resection was done in 7 (7.1%) cases. R0 resection was achieved in 62.2% of patients. There was one operative related mortality (1.02%) and 17.3% patients suffered procedure related complications. Local recurrence developed in 35 (35.7%) patients. The overall survival (OS) at 1, 3 and 5 years was 73.9%, 45.6% and 34.6% respectively and the median OS was 33 months (95% CI, 21.8-44.2), while median DFS was 24 months (95% CI, 19.6-28.4). Predictors of better DFS were -ve SM (P<0.001), tumors <5 cm (P=0.039), low grade (P=0.033), lower EBL (P=0.003) and absence of adjuvant therapy (P=0.007); however, on multivariate analysis, only -ve SM was the only predictor (HR =0.54; 95% CI, 0.29-0.97, P=0.041).

CONCLUSIONS:

In primary malignant CWTs (PMCWTs) achievement of wide resection margins is of great importance to minimize the local tumor recurrence that will have an adverse impact on long-term survival.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Ano de publicação: 2017 Tipo de documento: Article